These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

63 related items for PubMed ID: 1799463

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Selective loss of progenitor subsets following clinical CD34+ cell enrichment by magnetic field, magnetic beads or chromatography separation.
    Johnsen HE, Hutchings M, Taaning E, Rasmussen T, Knudsen LM, Hansen SW, Andersen H, Gaarsdal E, Jensen L, Nikolajsen K, Kjaesgârd E, Hansen NE.
    Bone Marrow Transplant; 1999 Dec; 24(12):1329-36. PubMed ID: 10627643
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. The generation of monoclonal anti-idiotype antibodies to human B cell-derived leukemias and lymphomas.
    Giardina SL, Schroff RW, Kipps TJ, Woodhouse CS, Abrams PG, Rager HC, Morgan AC, Foon KA.
    J Immunol; 1985 Jul; 135(1):653-8. PubMed ID: 3873497
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Some immunological properties of high and low tumorigenic cellular variants of c-H-ras transformed 3T3 cells.
    Gonen B, Ran M, Wreschner D, Cahalon L, Anavi R, Shlomo Y, Witz IP.
    Nat Immun Cell Growth Regul; 1988 Jul; 7(3):144-54. PubMed ID: 3050475
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Variants of an interspecies hybridoma with altered tumorigenicity and protective ability against mouse myeloma tumors.
    Baumal R, Musclow E, Farkas-Himsley H, Marks A.
    Cancer Res; 1982 May; 42(5):1904-8. PubMed ID: 7066902
    [Abstract] [Full Text] [Related]

  • 37. Afferent and efferent specificity in the induction and elicitation of parental cross-protective immunity by an immunogenic murine tumor variant: associative recognition of a unique tumor-specific antigen on somatic cell hybrids.
    LeGrue SJ, Ananthaswamy HN, Simcik WJ.
    Cancer Res; 1989 Sep 01; 49(17):4747-51. PubMed ID: 2474372
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. [Experimental analysis of intracerebral natural resistance against H-2+ and H-2- lymphomas grafted into the brain].
    Yamasaki T, Kikuchi H, Yamashita J, Ljunggren HG, Karre K, Klein G.
    No Shinkei Geka; 1989 Aug 01; 17(8):717-23. PubMed ID: 2586713
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 4.